Autoantibodies and autoantigens associated with autoimmune hepatitis <br /> and viruses-induced autoimmune response:<br /> Significant tools in clinical practice and in the study <br /> of pathogenesis of autoimmune hepatic diseases
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2004, Vol 21, Issue 6
Abstract
Autoimmune hepatitis (AIH) is a chronic necroinflammatory disease of the liver characterized by hypergammaglobulinemia, characteristic autoantibodies, association with HLA DR3 or DR4 and a favorable response to immunosuppressive treatment. The etiology is unknown. The detection of non-organ and liver-related autoantibodies remains the hallmark for the diagnosis of the disease in the absence of viral, metabolic, genetic, and toxic etiology of chronic hepatitis or hepatic injury. The current classification of AIH and the several autoantibodies/ target-autoantigens found in this disease are reported. Current aspects on the significance of these markers in the differential diagnosis and the study of pathogenesis of AIH are also stated. AIH is subdivided into two major types; AIH type 1 (AIH-1) and type 2 (AIH-2). AIH-1 is characterized by the detection of smooth muscle autoantibodies (SMA) and/or antinuclear antibodies (ANA). Determination of antineutrophil cytoplasmic autoantibodies (ANCA), antibodies against the asialoglycoprotein receptor (anti-ASGP-R) and antibodies against to soluble liver antigens or liver-pancreas (anti-SLA/LP) may be useful for the identification of patients who are seronegative for ANA/SMA. AIH-2 is characterized by the presence of specific autoantibodies against liver and kidney microsomal antigens (anti-LKM type 1 or infrequently anti-LKM type 3) and/or autoantibodies against liver cytosol 1 antigen (anti-LC1). Anti-LKM-1 and anti-LKM-3 autoantibodies are also detected in some patients with chronic hepatitis C (HCV) and chronic hepatitis D (HDV). Cytochrome P450 2D6 (CYP2D6) has been documented as the major target-autoantigen of anti-LKM-1 autoantibodies in both AIH-2 and HCV infection. Recent convincing data demonstrated the expression of CYP2D6 on the surface of hepatocytes suggesting a pathogenetic role of anti-LKM-1 autoantibodies for the liver damage. Family 1 of UDP-glucuronosyltransferases has been identified as the target-autoantigen of anti-LKM-3. For these reasons the distinction between AIH and chronic viral hepatitis (especially of HCV) is of particular importance. Recently, the molecular target of anti-SLA/LP and anti-LC1 autoantibodies were identified as a 50 kDa UGAsuppressor tRNA-associated protein and a liver specific enzyme, the formininotransferase cyclodeaminase, respectively. Anti-ASGP-R and anti-LC1 autoantibodies appear to correlate closely with disease severity and response to treatment suggesting a pathogenetic role of these autoantibodies for the hepatocellular injury. In general, however, autoantibodies should not be used to monitor treatment, predict AIH activity or outcome. Finally, the current aspects on a specific form of AIH that may develop in some patients with a rare genetic syndrome, the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) are also given. Autoantibodies against liver microsomes (anti-LM) are the specific autoantibodies detected in AIH as a disease component of APECED but also in cases of dihydralazine-induced hepatitis. Cytochrome P450 1A2 has been identified as the target-autoantigen of anti-LM autoantibodies in both APECED-related AIH and dihydralazine-induced hepatitis. The latter may indicate that similar autoimmune pathogenetic mechanisms can lead to liver injury in susceptible individuals irrespective of the primary defect. Characterization of the autoantigen-autoantibody repertoire continues to be an attractive and important tool to get access to the correct diagnosis and to gain insight into the as yet unresolved mystery of how hepatic tolerance is given up and AIH ensues.
Authors and Affiliations
G. DALEKOS
Keywords
Related Articles
- EP ID EP118449
- DOI -
- Views 40
- Downloads 0
Measurement of patient satisfaction: A method for improving hospital quality and effectiveness
OBJECTIVE Measurement of patient satisfaction with the healthcare services provided by six general public hospitals in Athens and estimation of the gap between the patients' expectations and the effectiveness of the hosp...
Arterial blood gas analyzers. Which is appropriate for point of care testing in the critical care unit?
OBJECTIVE Arterial blood gas analysis is a basic laboratory investigation in the critical care unit. In the past, a big problem in critical care management was the waiting period for arterial blood gas results from the l...
The impact of depressive symptoms on treatment satisfaction of patients with type 2 diabetes mellitus
OBJECTIVE To explore the association between depressive symptoms and treatment satisfaction in patients with type 2 diabetes mellitus (DM). METHOD The study was carried out on 162 consecutive patients with DM in the o...
Συγκριτική μελέτη της αγγειογενετικής δραστηριότητας ελεύθερων μοσχευμάτων<br /> στην αποκατάσταση πειραματικού ελλείμματος ουρήθρας σε κονίκλους
ΣΚΟΠΟΣ Σκοπός αυτής της πειραματικής μελέτης ήταν η εκτίμηση της αγγειογενετικής δραστηριότητας ελεύθερου μοσχεύματος πόσθης, καθώς και μοσχευμάτων βλεννογόνου στόματος και ουροδόχου κύστης, στην αποκατάσταση ελλείμματος...
Gaucher disease in Greece: Laboratory studies
OBJECTIVE The biochemical and molecular investigation of Gaucher disease in Greece. METHOD Clinically suspect cases over 20 years from all over Greece were studied. The biochemical investigations included assays of ch...